PPA
XENT

Parametric Portfolio Associates’s Intersect ENT, Inc XENT Stock Holding History

Parametric Portfolio Associates’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.09M Buy
38,959
+20,191
+108% +$553K ﹤0.01% 2741
2021
Q4 		$513K Sell
18,768
-4,958
-21% -$134K ﹤0.01% 3062
2021
Q3 		$645K Sell
23,726
-9,135
-28% -$226K ﹤0.01% 2987
2021
Q2 		$562K Sell
32,861
-3,012
-8% -$56.4K ﹤0.01% 3032
2021
Q1 		$749K Buy
35,873
+22
+0.1% +$508 ﹤0.01% 3293
2020
Q4 		$821K Sell
35,851
-24,186
-40% -$460K ﹤0.01% 3149
2020
Q3 		$979K Buy
60,037
+32,636
+119% +$591K ﹤0.01% 2930
2020
Q2 		$371K Sell
27,401
-9,693
-26% -$113K ﹤0.01% 3388
2020
Q1 		$440K Buy
37,094
+10,656
+40% +$236K ﹤0.01% 3235
2019
Q4 		$658K Buy
26,438
+1,112
+4% +$22.5K ﹤0.01% 3263
2019
Q3 		$431K Buy
25,326
+3,250
+15% +$59.2K ﹤0.01% 3398
2019
Q2 		$502K Sell
22,076
-3,855
-15% -$104K ﹤0.01% 3362
2019
Q1 		$834K Buy
25,931
+548
+2% +$17K ﹤0.01% 3112
2018
Q4 		$715K Sell
25,383
-4,497
-15% -$132K ﹤0.01% 3152
2018
Q3 		$859K Sell
29,880
-3,489
-10% -$105K ﹤0.01% 3182
2018
Q2 		$1.25M Sell
33,369
-36,472
-52% -$1.43M ﹤0.01% 2941
2018
Q1 		$2.75M Buy
69,841
+33,162
+90% +$1.21M ﹤0.01% 2374
2017
Q4 		$1.19M Sell
36,679
-70,636
-66% -$2.12M ﹤0.01% 2925
2017
Q3 		$3.34M Buy
107,315
+31,501
+42% +$932K ﹤0.01% 2195
2017
Q2 		$2.12M Buy
+75,814
New +$1.72M ﹤0.01% 2491
2016
Q2 		– Sell
-10,101
Closed -$192K – 3971
2016
Q1 		$192K Buy
10,101
+673
+7% +$12.2K ﹤0.01% 3754
2015
Q4 		$212K Sell
9,428
-23,300
-71% -$461K ﹤0.01% 3712
2015
Q3 		$766K Buy
32,728
+12,899
+65% +$356K ﹤0.01% 2487
2015
Q2 		$568K Buy
19,829
+5,525
+39% +$145K ﹤0.01% 3199
2015
Q1 		$369K Hold
14,304
– – ﹤0.01% 3437
2014
Q4 		$265K Buy
14,304
+233
+2% +$4.19K ﹤0.01% 3646
2014
Q3 		$218K Buy
+14,071
New +$212K ﹤0.01% 3587

Other funds holding XENT

VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.05B AUM 111.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Parametric Portfolio Associates's XENT Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Intersect ENT, Inc (XENT) stake by 108% in Q1 2022, buying an estimated $553K and bringing the position to 38,959 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2741.

Parametric Portfolio Associates first reported a position in XENT in Q3 2014 and has held it in 27 quarters since. The position peaked at $3.34M in Q3 2017. 131 funds tracked by Wall St. Rank hold XENT as of Q1 2022.

  • Parametric Portfolio Associates held 38,959 shares of Intersect ENT, Inc worth $1.09M as of Q1 2022.
  • Parametric Portfolio Associates bought 20,191 Intersect ENT, Inc shares in Q1 2022, an estimated $553K.
  • Intersect ENT, Inc made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2741 holding.
  • Parametric Portfolio Associates first reported a position in Intersect ENT, Inc in Q3 2014 and has held it in 27 quarters since.
  • Parametric Portfolio Associates's Intersect ENT, Inc position peaked at $3.34M in Q3 2017.
  • 131 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.